Approval Status: Approved April 1998
Treatment for: oral contraception
Areas: Diabetes / Endocrinology; Pregnancy & Gynecology
Mircette has been approved as an oral contraceptive in the U.S. Mircette tablets are the first oral contraceptive to use a shortened hormone-free interval. The Mircette regime reduces the daily estrogen dose from the commonly prescribed 30-35 mcg level to the 20 mcg level, while maintaining cycle control and a favorable tolerability profile.
Mircette Drug Information
The Mircette drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.